THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
63 hedge funds and large institutions have $95.5M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-6
Holders Change %
-8.7%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
10
Increased
19
Reduced
21
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
$4.62M |
| 2 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
$11.1M |
| 3 |
O
OrbiMed
New York
|
$47.6M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
$696K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
$1.08M |
